Findings from Johnson & Johnson Broaden Understanding of Cauda Equina Syndrome (Racial and Health Insurance Differences In Patient Outcomes After Surgical Treatment for Cauda Equina Syndrome): Diseases and Conditions – Cauda Equina Syndrome

2023 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- Current study results on Diseases and Conditions - Cauda Equina Syndrome have been published. According to news reporting from New Brunswick, New Jersey, by NewsRx journalists, research stated, “Design.Retrospective database evaluation.Objectives.To study the association between race, health care insurance, mortality, postoperative visits, and reoperation within a hospital setting in patients with cauda equina syndrome (CES) undergoing surgical intervention.Summary of Background Data.CES can lead to permanent neurological deficits if the diagnosis is missed or delayed. Evidence of racial or insurance disparities in CES is sparse.Materials and Methods.Patients with CES undergoing surgery from 2000 to 2021 were identified from the Premier Health care Database.”

Financial support for this research came from The authors thank Natalie Edwards of Health Services Consulting Corporation, Boxborough, MA, USA for editorial assistance with the manuscript..

The news correspondents obtained a quote from the research from Johnson & Johnson, “Six-month postoperative visits and 12-month reoperations within the hospital were compared by race (i.e., White, Black, or Other [Asian, Hispanic, or other]) and insurance (i.e., Commercial, Medicaid, Medicare, or Other) using Cox proportional hazard regressions; covariates were used in the regression models to control for confounding. Likelihood ratio tests were used to compare model fit.Results.Among 25,024 patients, most were White (76.3%), followed by Other race (15.4% [ 8.8% Asian, 7.3% Hispanic, and 83.9% other]) and Black (8.3%). Models with race and insurance combined provided the best fit for estimating the risk of visits to any setting of care and reoperations. White Medicaid patients had the strongest association with a higher risk of 6-month visits to any setting of care versus White patients with commercial insurance (HR: 1.36 (1.26,1.47)). Being Black with Medicare had a strong association with a higher risk of 12-month reoperations versus White commercial patients (HR: 1.43 (1.10,1.85)). Having Medicaid versus Commercial insurance was strongly associated with a higher risk of complication-related (HR: 1.36 (1.21, 1.52)) and ER visits (HR: 2.26 (2.02,2.51)). Medicaid had a significantly higher risk of mortality compared with Commercial patients (HR: 3.19 (1.41,7.20)).Conclusions.Visits to any setting of care, complication-related, ER visits, reoperation, or mortality within the hospital setting after CES surgical treatment varied by race and insurance.”

According to the news reporters, the research concluded: “Insurance type had a stronger association with the outcomes than race.Level of Evidence.Level-III.”

This research has been peer-reviewed.

For more information on this research see: Racial and Health Insurance Differences In Patient Outcomes After Surgical Treatment for Cauda Equina Syndrome. Spine, 2023;48(19):1373-1387. Spine can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA. (Lippincott Williams and Wilkins - www.lww.com; Spine - http://journals.lww.com/spinejournal/pages/default.aspx)

Our news journalists report that additional information may be obtained by contacting Katherine A. Corso, Johnson & Johnson, Med Devices Epidemiol Real World Data Sci, New Brunswick, NJ, United States. Additional authors for this research include Jill Ruppenkamp, Chantal E. Holy, Paul M. Coplan, Peter Joo and Addisu Mesfin.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1097/BRS.0000000000004727. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)